CVS
NYSE · Health Care
Cvs Health Corp
$95.89
-1.26 (-1.30%)
Financial Highlights (FY 2026)
Revenue
409.35B
Net Income
1.80B
Gross Margin
13.8%
Profit Margin
0.4%
Rev Growth
+7.6%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 13.8% | 13.8% | 57.0% | 57.0% |
| Operating Margin | 1.3% | 1.2% | 11.7% | 11.7% |
| Profit Margin | 0.4% | 0.4% | 10.7% | 12.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 409.35B | 380.33B | 35.14B | 41.63B |
| Gross Profit | 56.37B | 52.37B | 20.04B | 23.74B |
| Operating Income | 5.24B | 4.38B | 4.11B | 4.87B |
| Net Income | 1.80B | 1.51B | 3.75B | 4.98B |
| Gross Margin | 13.8% | 13.8% | 57.0% | 57.0% |
| Operating Margin | 1.3% | 1.2% | 11.7% | 11.7% |
| Profit Margin | 0.4% | 0.4% | 10.7% | 12.0% |
| Rev Growth | +7.6% | +7.6% | +2.0% | -5.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 28.66B | 28.66B | 20.32B | 24.89B |
| Total Equity | 33.38B | 33.38B | 34.75B | 38.76B |
| D/E Ratio | 0.86 | 0.86 | 0.58 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 5.35B | 4.72B | 5.77B | 6.52B |
| Free Cash Flow | — | — | 4.73B | 6.70B |